Apr 23 |
Acurx Pharmaceuticals, Inc. to Discuss First Quarter 2024 Financial Results on May 15, 2024 Conference Call and Provide Business Update
|
Mar 21 |
Acurx Pharmaceuticals, Inc. Announces Participation in the LD Micro Invitational XIV
|
Mar 19 |
Acurx files common stock offering, no amount given
|
Mar 19 |
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2023 Earnings Call Transcript
|
Mar 19 |
Q4 2023 Acurx Pharmaceuticals Inc Earnings Call
|
Mar 18 |
Acurx Pharmaceuticals, Inc. (ACXP) Q4 2023 Earnings Call Transcript
|
Mar 18 |
Acurx Pharmaceuticals GAAP EPS of -$0.37
|
Mar 18 |
We Think Acurx Pharmaceuticals (NASDAQ:ACXP) Needs To Drive Business Growth Carefully
|
Mar 18 |
Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
|
Mar 18 |
Earnings Scheduled For March 18, 2024
|